Literature DB >> 20650671

Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease.

Scott Bickel1, Lazaro Alvarez, Raul Macias, Nancy Pavon, Miraida Leon, Cristina Fernandez, David J Houghton, Sonia Salazar, Maria C Rodríguez-Oroz, Jorge Juncos, Jorge Guridi, Mahlon Delong, Jose A Obeso, Irene Litvan.   

Abstract

Since the advent of deep brain stimulation (DBS) for the treatment of Parkinson's disease (PD), subsequent cognitive and neuropsychiatric effects of this procedure have become well-chronicled. Yet, thermolitic lesion of the subthalamic nucleus (STN) is still a valid option when DBS cannot be applied, and little has been published regarding its impact on cognition and mood. We examined the cognitive and neuropsychiatric functions of 10 consecutive patients with advanced PD undergoing simultaneous bilateral subthalamotomies. With 24 months of follow-up, the patients, three of whom were on anticholinergics prior to surgery, showed no deterioration in cognitive assessments including verbal fluency. Hypoactive behaviors (depression and apathy) showed lasting improvement, while hyperactive behaviors (euphoria and disinhibition) transiently increased after surgery. Improvement in hypoactive behaviors correlated with improvement in hypokinetic movements, and enhanced hyperactive behaviors followed the course of post-operative hyperkinetic movements. Such correlations may support the role of the STN in modulating limbic connections between the basal ganglia and frontal cortex. The results of this proof-of-concept pilot study suggest the need for larger, long-term, randomized controlled studies to assess motor, neuropsychiatric, behavioral and radiologic correlations after subthalamotomies.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20650671     DOI: 10.1016/j.parkreldis.2010.06.008

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

Review 2.  Inhibitory dysfunction contributes to some of the motor and non-motor symptoms of movement disorders and psychiatric disorders.

Authors:  Marjan Jahanshahi; John C Rothwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-04-19       Impact factor: 6.237

Review 3.  The Subthalamic Nucleus, Limbic Function, and Impulse Control.

Authors:  P Justin Rossi; Aysegul Gunduz; Michael S Okun
Journal:  Neuropsychol Rev       Date:  2015-11-14       Impact factor: 7.444

4.  Early dysfunction and progressive degeneration of the subthalamic nucleus in mouse models of Huntington's disease.

Authors:  Jeremy F Atherton; Eileen L McIver; Matthew Rm Mullen; David L Wokosin; D James Surmeier; Mark D Bevan
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

Review 5.  Meta-Analysis of the Relationship between Deep Brain Stimulation in Patients with Parkinson's Disease and Performance in Evaluation Tests for Executive Brain Functions.

Authors:  A M Martínez-Martínez; O M Aguilar; C A Acevedo-Triana
Journal:  Parkinsons Dis       Date:  2017-02-08

6.  Subthalamic hGAD65 gene therapy and striatum TH gene transfer in a Parkinson's disease rat model.

Authors:  Deyu Zheng; Xiaohua Jiang; Junpeng Zhao; Deyi Duan; Huanying Zhao; Qunyuan Xu
Journal:  Neural Plast       Date:  2013-04-29       Impact factor: 3.599

7.  Older Candidates for Subthalamic Deep Brain Stimulation in Parkinson's Disease Have a Higher Incidence of Psychiatric Serious Adverse Events.

Authors:  Vitalii V Cozac; Michael M Ehrensperger; Ute Gschwandtner; Florian Hatz; Antonia Meyer; Andreas U Monsch; Michael Schuepbach; Ethan Taub; Peter Fuhr
Journal:  Front Aging Neurosci       Date:  2016-06-08       Impact factor: 5.750

Review 8.  Cognitive assessment instruments in Parkinson's disease patients undergoing deep brain stimulation.

Authors:  Aline Juliane Romann; Silvia Dornelles; Nicole de Liz Maineri; Carlos Roberto de Mello Rieder; Maira Rozenfeld Olchik
Journal:  Dement Neuropsychol       Date:  2012 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.